Preeclampsia Breakthrough from Aston University
A brief summary of our “ground-breaking study”
Preeclampsia is the most common serious pregnancy complication, affecting 4-8% of all pregnancies worldwide with potentially severe consequences for both mother and baby. The Vascular Research team at Aston University have a wealth of experience in preeclampsia study, and much of our work is focused on trying to elucidate the etiology of this complex condition and developing new therapies to ameliorate it’s effects.
In June 2013 the results of our most recent study into preeclampsia were published in the preeminent cardiovascular journal Circulation. The study examines the role of Hydrogen Sulfide, a naturally-occurring gas known for it’s “rotten egg” odour, in the development of preeclampsia. The findings of this research project are potentially extremely significant; in addition to identifying a novel factor contributing to the development of preeclampsia symptoms, it presents the possibility of developing an effective treatment for the disorder within the near future. It was described by Circulation as being a “ground-breaking study”, and has also received mainstream media attention.
The images below are taken from a presentation about the aforementioned research study and concisely summarise our aims and findings.
Click on individual slides to view them full-screen.
- An Introduction to Preeclampsia
- Vascular Research at Aston University
- The latest Preeclampsia research findings from Vascular Aston
- Testing Potential Preeclampsia Therapies – The StAmP Trial
- “Aston researchers help fight life-threatening pregnancy condition”
- Breakthrough in fight against pre-eclampsia: Scientists may have found cause of the life-threatening pregnancy condition
- Dysregulation of Hydrogen Sulfide Producing Enzyme Cystathionine γ-lyase Contributes to Maternal Hypertension and Placental Abnormalities in Preeclampsia